Company Search:
Advanced Search
Sponsored Links
Albany Molecular Research Incorporated Company Snapshot
Albany Molecular Research Incorporated operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Albany Molecular Research Incorporated with three other companies in this sector in the United States: Five Prime Therapeutics Inc (2015 sales of $379.80 million ), Medpace Holdings Inc ($320.10 million ), and Insys Therapeutics Incorporated ($330.80 million of which 100% was Non-Drug Products).

Sales Analysis. Albany Molecular Research Incorporated reported sales of $402.36 million for the year ending December of 2015. This represents an increase of 45.5% versus 2014, when the company's sales were $276.57 million. Sales at Albany Molecular Research Incorporated have increased during each of the previous five years (and since 2010, sales have increased a total of 103%). Sales of Drug Products saw an increase that was more than double the company's growth rate: sales were up 203.5% in 2015, from $29.62 million to $89.90 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Albany Molecular Research Incorporated
  Stock Performance Chart for Albany Molecular Research Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 18.61
(Figures in U.S. Dollars)
1 Week -0.3%   13 Weeks 5.4%  
4 Weeks 7.2%   52 Weeks 21.6%  
Albany Molecular Research Incorporated Key Data:
  Ticker: AMRI Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 402,356,000
(Year Ending Jan 2016).
Employees: 2,220
  Currency: U.S. Dollars Market Cap: 798,199,519
  Fiscal Yr Ends: December Shares Outstanding: 42,890,893
  Share Type: Common Closely Held Shares: 12,994,557
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.